Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma

Fig. 4

Many HCC drug target tyrosine kinases receptors show variable expression changes across different patients. A: Normalized gene expression and their respective log2FoldChange values from per-patient analysis of VEGFR2. B-D: Log2FoldChange barplots from per-patient analysis of VEGFRs (B), PDGFRs (C) and FGFRs (D). Patient orders are not the same across A, B, C and D

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us